Rafferty Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.45M | Buy |
|
|||||
|
2025
Q1 | $2.14M | Sell |
|
|||||
|
2024
Q4 | $3.69M | Buy |
|
|||||
|
2024
Q3 | $4.04M | Buy |
|
|||||
|
2024
Q2 | $2.61M | Sell |
|
|||||
|
2024
Q1 | $6.92M | Buy |
|
|||||
|
2023
Q4 | $3.85M | Sell |
|
|||||
|
2023
Q3 | $5.84M | Buy |
|
|||||
|
2023
Q2 | $7.88M | Buy |
|
|||||
|
2023
Q1 | $3.53M | Sell |
|
|||||
|
2022
Q4 | $3.22M | Sell |
|
|||||
|
2022
Q3 | $2.92M | Buy |
|
|||||
|
2022
Q2 | $2.49M | Buy |
|
|||||
|
2022
Q1 | $4.93M | Buy |
|
|||||
|
2021
Q4 | $5.67M | Buy |
|
|||||
|
2021
Q3 | $1.23M | Buy |
|
|||||
|
2021
Q2 | $1.76M | Sell |
|
|||||
|
2021
Q1 | $1.97M | Buy |
|
|||||
|
2020
Q4 | $280K | Sell |
|
|||||
|
2020
Q3 | $547K | Buy |
|